Phenethylamine in normal urine: failure to verify high values.

Area of Science:

• Biochemistry
• Neuroscience
• Clinical Chemistry

Background:

• Phenethylamine (PEA) is a neuromodulator with potential roles in mood and behavior.
• Previous research has suggested altered PEA levels in psychiatric conditions.
• Accurate measurement of PEA in biological samples is crucial for understanding its physiological and pathological significance.

Purpose of the Study:

• To quantify the daily urinary excretion of phenethylamine (PEA) in normal subjects.
• To investigate the presence of a circadian rhythm in PEA excretion.
• To compare PEA levels in acute schizophrenic patients with those of normal individuals.

Main Methods:

• Utilized an isotope dilution technique for precise PEA quantification.
• Employed a multi-step purification process including thin-layer chromatography (TLC) and gas chromatography (electron capture).
• Analyzed both daytime urine samples and 24-hour urine collections.

Main Results:

• The mean daily urinary output of PEA in normal subjects was determined to be 10.3 µg/day.
• Analysis of 24-hour urine collections did not reveal a significant circadian rhythm in PEA excretion.
• Urinary PEA levels in three acute schizophrenic patients were found to be within the normal range.

Conclusions:

• Established a reference range for daily urinary PEA excretion in healthy individuals.
• Indicated that PEA excretion does not exhibit a clear circadian pattern.
• Suggests that acute schizophrenia may not be associated with significantly altered urinary PEA levels.